The Evidence Layer for Scientific AI

 Quick Explanation Copied

 Long Explanation

Roger W. Innes's body of work, spanning 2005 to 2026, demonstrates sustained methodological depth and a trajectory from classical genetics toward cell-biological mechanisms of intercellular communication in plant immunity. Three strands of evidence define his scientific strength.

1. Genetic dissection of defense negative regulators

Innes's EMS mutagenesis screens yielded foundational discoveries. The edr2 mutant screen (~12,000 M2 plants from ~3,000 M1 parents) identified EDR2 (At4g19040), a PH/START-domain protein negatively regulating SA-dependent powdery mildew resistance and cell death, with complementation in 27 of 30 transgenic plants confirming causality EDR2 PH/START negative defense regulator. A later screen of 60,000 M2 seedlings from 3,500 edr1 M1 plants identified eed3, mapping to GSL5 (At4g03550); loss of both EDR1 and GSL5 triggers synergistic SA/JA defense activation with severe dwarfism and necrosis, and the edr1 pmr4-1 double mutant segregated 4:70 dwarfed plants (chi-squared 0.09, p = 0.76, consistent with 1:15 expected) GSL5-EDR1 synergistic defense activation.

2. Structure-function precision in NLR immunity

Transient structure-function assays of RPS5 showed the CC domain is dispensable for PBS1-cleavage recognition while the LRR both suppresses autoactivation (first four LRRs sufficient) and is required for recognition, and that N-terminal acylation-dependent plasma membrane localization is essential RPS5 CC/LRR domain function. Notably, key native-expression tests were reported only as 'data not shown' and pathogen resistance was not directly assayed—a transparency gap worth noting. Relatedly, Innes's lab showed KEG regulates vacuolar trafficking and is degraded during fungal infection KEG protein trafficking regulator.

3. Extracellular vesicle frontier

Innes's recent work established that geminiviruses exploit plant apoplastic EVs: NTA showed EV enrichment in infected plants; DNase protection revealed encapsulated viral DNA; rolling circle amplification detected complete circular CabLCV DNA A/B; P40 fractions infected naive plants (symptoms at 28 dpi); and proteomics identified 1,989 host proteins plus viral CP/NSP/MP, with ~92% overlap with previously reported Arabidopsis EV proteomes Geminiviruses exploit plant EVs. The lab also discovered EVacs—1-5 µm tonoplast-derived bodies mediating secretion of full-length tRNAs, rRNAs, and mRNAs—though the mechanism of vacuolar escape remains unresolved and functional RNA transfer is not demonstrated EVacs mediate plant RNA secretion. A companion review maps mechanisms of EV subpopulation production, implicating EXO70 and RIN4 in fungal immunity Plant EV biogenesis mechanisms.

Limitations and blind spots

Key uncertainties remain: single-vesicle localization of geminiviral genomes is not visualized; the EV loading mechanism is undefined; EVac escape from the vacuole is unresolved; several RPS5 native-level tests were 'data not shown'; and findings are anchored in Arabidopsis/N. benthamiana, limiting generality. A declared advisory-board role (Terrana Biosciences) on the EVacs paper warrants scrutiny of RNA-technology framing, though the mechanism claims are well-evidenced independently. Overall, the evidence record shows an author who consistently combines large-scale genetics with mechanistic cell biology and whose recent EV work is genuinely field-opening.

 BGPT Author Review

Scientific Quality

Innes demonstrates exceptional scientific depth: large-scale EMS screens (12,000-60,000 M2 plants) yielding mapped, complemented genes; rigorous domain-dissection of NLR function; and pioneering, multi-method EV biology (NTA, proteomics, DNase protection, infectivity). Minor deductions for 'data not shown' transparency gaps in some native-level RPS5 tests and incomplete mechanistic closure in EV work.

Communication Quality

Papers present clear designs, controls (mock infections, marker exclusions like SYP61, segregation tests with chi-squared analysis), and honest limitation statements (e.g., explicitly listing unresolved EVac escape mechanisms). Some quantitative results (qRT-PCR fold-changes) are relegated to figures rather than reported numerically, slightly reducing standalone clarity.

Author Novelty

Early work (EDR2, EDR1/GSL5) was foundational for defense negative-regulator biology; recent EV work—geminiviral EV carriage and EVac-mediated RNA secretion—is genuinely field-opening, with EVacs described as a novel unconventional secretion route. The RPS5 structure-function study is solid but more incremental.

Scientific Rigor

Strengths include biological triplicates, appropriate controls (negative EV markers, DNase/sonication disrupt controls, mock infections), statistical segregation tests, and explicit falsification-relevant limitations. Deductions: bulk P40 fractions rather than single-vesicle resolution, reliance on transient overexpression in RPS5 work, and missing direct tests of some proposed mechanisms.